Related Experiment Video
Updated: May 14, 2026

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Breast cancer in patients with sickle cell disease can be treated safely with weekly paclitaxel
1Department of Oncology and Hematology, Salmaniya Medical Complex, Manama, Bahrain. AZaman@health.gov.bh
Abstract:
Breast cancer is the most common malignancy among females; nevertheless, so far no data is available in the literature on the safety of oncological treatments in patients with sickle cell disease (SCD). Here we report a case of a 39-year-woman with SCD who presented with metastatic breast cancer, and was treated accordingly with weekly paclitaxel 80 mg/m2 day one, 8, and 15 every 28 days as a standard regimen for metastatic breast cancer. She managed to complete the full course of chemotherapy (18 doses) of weekly treatment without any dose reductions or delays. The main side effects were: grade 1 nausea; and grade 2 mucositis. However, surprisingly there was no episode of febrile neutropenia, anemia, or thrombocytopenia. Moreover, she had no vaso-occlusive crisis while on chemotherapy. Therefore, weekly paclitaxel is both safe and well tolerated in SCD patients with breast cancer.
Related Concept Videos
Drugs that Stabilize Microtubules
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
iPS Cell Differentiation
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Treatment Resistant Cancers

